APA (7th ed.) Citation

Cox, T. M., Drelichman, G. I., Cravo, R., Balwani, M., Burrow, T. A., Martins, A. M., . . . Peterschmitt, M. J. (2015). ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results. Molecular Genetics & Metabolism, 114(2), S33. https://doi.org/10.1016/j.ymgme.2014.12.058

Chicago Style (17th ed.) Citation

Cox, Timothy M., et al. "ENCORE, a Randomized, Controlled, Open-label Non-inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy: 24-month Results." Molecular Genetics & Metabolism 114, no. 2 (2015): S33. https://doi.org/10.1016/j.ymgme.2014.12.058.

MLA (9th ed.) Citation

Cox, Timothy M., et al. "ENCORE, a Randomized, Controlled, Open-label Non-inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy: 24-month Results." Molecular Genetics & Metabolism, vol. 114, no. 2, 2015, p. S33, https://doi.org/10.1016/j.ymgme.2014.12.058.